e 64 has been researched along with topotecan in 1 studies
| Studies (e 64) | Trials (e 64) | Recent Studies (post-2010) (e 64) | Studies (topotecan) | Trials (topotecan) | Recent Studies (post-2010) (topotecan) |
|---|---|---|---|---|---|
| 477 | 1 | 103 | 2,392 | 626 | 792 |
| Protein | Taxonomy | e 64 (IC50) | topotecan (IC50) |
|---|---|---|---|
| Cytochrome P450 3A4 | Homo sapiens (human) | 1.5211 | |
| DNA topoisomerase 1 | Homo sapiens (human) | 0.8525 | |
| DNA topoisomerase 2-alpha | Homo sapiens (human) | 0.605 | |
| DNA topoisomerase 2-beta | Homo sapiens (human) | 0.605 | |
| Hypoxia-inducible factor 1-alpha | Homo sapiens (human) | 0.06 | |
| Multidrug and toxin extrusion protein 2 | Homo sapiens (human) | 8.6 | |
| Multidrug and toxin extrusion protein 1 | Homo sapiens (human) | 1.3 | |
| Broad substrate specificity ATP-binding cassette transporter ABCG2 | Homo sapiens (human) | 0.17 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Harada, M; Okuno, S; Sakakibara, H; Suzuki, T; Yano, T | 1 |
1 other study(ies) available for e 64 and topotecan
| Article | Year |
|---|---|
Determinants for the drug release from T-0128, camptothecin analogue-carboxymethyl dextran conjugate.
Topics: Animals; Antineoplastic Agents, Phytogenic; Cattle; Cysteine Endopeptidases; Dextrans; Dipeptides; Humans; Leucine; Male; Mammary Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Prodrugs; Rats; Solubility; Species Specificity; Topotecan | 2000 |